About this data
What it is
The FDA publishes its decisions on drugs and medical devices through openFDA. We list approved drug applications and the changes approved to them, 510(k) clearances of devices and premarket approvals (PMA) of higher-risk devices, and match the applicant to a public company when the name lines up. The page opens on new brand-name drugs and biologics: the first approval of a new drug application (NDA) or biologics license application (BLA).
Who files it
The FDA decides; openFDA publishes the FDA's records. The applicant is the company named in the FDA's record for the application.
How current
We check openFDA every day. The FDA refreshes its files on its own schedule, and a decision can appear days to weeks after its date, so the latest approvals may show up late.
Terms
openFDAopenFDA is the FDA's public data service. It publishes the FDA's own records of drug approvals and device decisions. openFDA asks users not to imply that the FDA endorses their product or service: this site is not endorsed by or affiliated with the FDA.NDA and BLAA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original.supplementA later approved change to a drug that is already on the market: a new use, a new dose, a label change or a manufacturing change. Many supplements are minor.generic drugsA generic drug (an ANDA, or abbreviated new drug application) is approved because it matches a drug already on the market. Generics are made by many companies, most of which are not public.510(k)A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval.PMAPremarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.company matchWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.
Worth knowing
This is a record of decisions already made. It is not a calendar of coming decisions: a drug under review does not appear, and we show no review dates. openFDA asks users not to imply that the FDA endorses their product or service: this page is not endorsed by or affiliated with the FDA, and the FDA makes no warranty about the data. It is not for medical decisions. Most applicants, such as generic makers and private device makers, do not match a public company, and a subsidiary or a differently spelled name can be missed, so a row with no ticker may still belong to one. A clearance is not an approval, and many approved supplements are minor.
Not to be confused with
Clinical trial updates: what sponsors report about their studies, not what the FDA decided.

All of this comes from openFDA, the FDA's public data service. This site is not endorsed by or affiliated with the FDA.

FDA decisions per day, last 30 days

010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0
010203040Oct 17 · Brand-name drugs and biologics, with supplements: 0Oct 17 · Device clearances and approvals: 0Oct 17Oct 18 · Brand-name drugs and biologics, with supplements: 0Oct 18 · Device clearances and approvals: 1Oct 19 · Brand-name drugs and biologics, with supplements: 4Oct 19 · Device clearances and approvals: 10Oct 20 · Brand-name drugs and biologics, with supplements: 3Oct 20 · Device clearances and approvals: 12Oct 21 · Brand-name drugs and biologics, with supplements: 6Oct 21 · Device clearances and approvals: 18Oct 21Oct 22 · Brand-name drugs and biologics, with supplements: 6Oct 22 · Device clearances and approvals: 15Oct 23 · Brand-name drugs and biologics, with supplements: 7Oct 23 · Device clearances and approvals: 24Oct 24 · Brand-name drugs and biologics, with supplements: 0Oct 24 · Device clearances and approvals: 1Oct 25 · Brand-name drugs and biologics, with supplements: 0Oct 25 · Device clearances and approvals: 1Oct 25Oct 26 · Brand-name drugs and biologics, with supplements: 4Oct 26 · Device clearances and approvals: 17Oct 27 · Brand-name drugs and biologics, with supplements: 5Oct 27 · Device clearances and approvals: 18Oct 28 · Brand-name drugs and biologics, with supplements: 2Oct 28 · Device clearances and approvals: 15Oct 29 · Brand-name drugs and biologics, with supplements: 3Oct 29 · Device clearances and approvals: 27Oct 29Oct 30 · Brand-name drugs and biologics, with supplements: 6Oct 30 · Device clearances and approvals: 32Oct 31 · Brand-name drugs and biologics, with supplements: 0Oct 31 · Device clearances and approvals: 0Nov 1 · Brand-name drugs and biologics, with supplements: 0Nov 1 · Device clearances and approvals: 0Nov 2 · Brand-name drugs and biologics, with supplements: 1Nov 2 · Device clearances and approvals: 0Nov 2Nov 3 · Brand-name drugs and biologics, with supplements: 1Nov 3 · Device clearances and approvals: 0Nov 4 · Brand-name drugs and biologics, with supplements: 3Nov 4 · Device clearances and approvals: 0Nov 5 · Brand-name drugs and biologics, with supplements: 2Nov 5 · Device clearances and approvals: 0Nov 6 · Brand-name drugs and biologics, with supplements: 4Nov 6 · Device clearances and approvals: 0Nov 6Nov 7 · Brand-name drugs and biologics, with supplements: 0Nov 7 · Device clearances and approvals: 0Nov 8 · Brand-name drugs and biologics, with supplements: 0Nov 8 · Device clearances and approvals: 0Nov 9 · Brand-name drugs and biologics, with supplements: 5Nov 9 · Device clearances and approvals: 0Nov 10 · Brand-name drugs and biologics, with supplements: 5Nov 10 · Device clearances and approvals: 0Nov 10Nov 11 · Brand-name drugs and biologics, with supplements: 1Nov 11 · Device clearances and approvals: 0Nov 12 · Brand-name drugs and biologics, with supplements: 0Nov 12 · Device clearances and approvals: 0Nov 13 · Brand-name drugs and biologics, with supplements: 0Nov 13 · Device clearances and approvals: 0Nov 14 · Brand-name drugs and biologics, with supplements: 0Nov 14 · Device clearances and approvals: 0Nov 14Nov 15 · Brand-name drugs and biologics, with supplements: 0Nov 15 · Device clearances and approvals: 0

Brand-name drugs and biologics, with supplements Device clearances and approvals

By the FDA's decision date. Generic drugs are left out. The FDA's files can lag a decision by days to weeks, so the most recent days fill in later.

Latest FDA decisions

Reset

Showing: ticker TEVA · Everything

Latest FDA decisions
DecidedProductApplicantWe match the applicant's name to a public company automatically, and by hand for the large drugmakers. Most applicants, such as generic makers and private device makers, do not match, and a subsidiary or a differently spelled name can be missed.DecisionA new drug application (NDA) asks the FDA to approve a drug made from chemicals. A biologics license application (BLA) asks for a biologic, such as an antibody or a vaccine. The first approval is the original. A device maker shows the FDA that its device is substantially equivalent to one already sold. The FDA clears it, which is a lighter review than an approval. Premarket approval: the FDA's strictest review, for higher-risk devices. The maker must show the device is safe and effective.FDA page
Nov 9, 2026ANASTROZOLE
ANASTROZOLE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA078058 ↗
Nov 3, 2026FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE
TEVA
Teva Pharmaceuticals USA Inc
Generic (ANDA)
UNKNOWN
ANDA209917 ↗
Oct 27, 2026RIVAROXABAN
RIVAROXABAN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA)
UNKNOWN
ANDA212247 ↗
Oct 19, 2026DEFLAZACORT
DEFLAZACORT
TEVA
Teva Pharmaceuticals Inc
Generic (ANDA)
UNKNOWN
ANDA217103 ↗
Oct 15, 2026MESALAMINE
MESALAMINE
TEVA
Teva Pharmaceuticals Inc
Generic (ANDA), supplement
Labeling
ANDA213191 ↗
Oct 15, 2026MESALAMINE
MESALAMINE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
Labeling
ANDA207873 ↗
Oct 8, 2026WELTRUZA
OLANZAPINE
TEVA
Teva
New drug (NDA)
Type 5 - New Formulation or New Manufac…
NDA219007 ↗
Oct 7, 2026CLARAVIS
ISOTRETINOIN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA076356 ↗
Oct 7, 2026CLARAVIS
ISOTRETINOIN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA076135 ↗
Oct 6, 2026PROGLYCEM
DIAZOXIDE
TEVA
Teva Branded Pharm
New drug (NDA), supplement
Labeling
NDA017453 ↗
Sep 29, 2026PONLIMSI
DENOSUMAB-ADET
TEVA
Teva Pharmaceuticals, Inc.
Biologic (BLA), supplement
BIOSIMILAR
BLA761385 ↗
Sep 28, 2026DEXMETHYLPHENIDATE HYDROCHLORIDE
DEXMETHYLPHENIDATE HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA077107 ↗
Sep 28, 2026DEXMETHYLPHENIDATE HYDROCHLORIDE
DEXMETHYLPHENIDATE HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA077107 ↗
Sep 28, 2026DEXMETHYLPHENIDATE HYDROCHLORIDE
DEXMETHYLPHENIDATE HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA077107 ↗
Sep 25, 2026DEGEVMA
DENOSUMAB-ADET
TEVA
Teva Pharmaceuticals, Inc.
Biologic (BLA)
Type 5 - New Formulation or New Manufac…
BLA761481 ↗
Sep 24, 2026DORZOLAMIDE HYDROCHLORIDE
DORZOLAMIDE HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA078756 ↗
Sep 17, 2026PALONOSETRON HYDROCHLORIDE
PALONOSETRON HYDROCHLORIDE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
Labeling
ANDA090713 ↗
Sep 15, 2026CARBAMAZEPINE
CARBAMAZEPINE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA078592 ↗
Sep 11, 2026PACLITAXEL
PACLITAXEL
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA075184 ↗
Aug 21, 2026CLARAVIS
ISOTRETINOIN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
Labeling
ANDA076356 ↗
Aug 21, 2026CLARAVIS
ISOTRETINOIN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
Labeling
ANDA076135 ↗
Aug 17, 2026TOFACITINIB CITRATE
TOFACITINIB CITRATE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA)
UNKNOWN
ANDA209813 ↗
Aug 14, 2026BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA091149 ↗
Aug 11, 2026VARDENAFIL HYDROCHLORIDE
VARDENAFIL HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA091347 ↗
Aug 11, 2026GLIPIZIDE AND METFORMIN HYDROCHLORIDE
GLIPIZIDE; METFORMIN HYDROCHLORIDE
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA077270 ↗
Aug 11, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
TEVA
Teva
Generic (ANDA), supplement
Labeling
ANDA076864 ↗
Aug 11, 2026GLYBURIDE AND METFORMIN HYDROCHLORIDE
GLYBURIDE; METFORMIN HYDROCHLORIDE
TEVA
Teva
Generic (ANDA), supplement
Labeling
ANDA076821 ↗
Aug 11, 2026METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE
TEVA
Teva
Generic (ANDA), supplement
Labeling
ANDA076269 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA211272 ↗
Jul 29, 2026MYCOPHENOLATE SODIUM
MYCOPHENOLATE SODIUM
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA202720 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
REMS
ANDA065491 ↗
Jul 29, 2026MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
REMS
ANDA065457 ↗
Jul 28, 2026SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
TEVA
Teva Pharmaceuticals USA Inc
Generic (ANDA)
UNKNOWN
ANDA214126 ↗
Jul 24, 2026BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
TEVA
Teva Branded Pharm
New drug (NDA), supplement
Labeling
NDA020186 ↗
Jul 21, 2026TOLVAPTAN
TOLVAPTAN
TEVA
Teva Pharmaceuticals Inc
Generic (ANDA)
UNKNOWN
ANDA216933 ↗
Jul 13, 2026ELTROMBOPAG OLAMINE
ELTROMBOPAG OLAMINE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA)
UNKNOWN
ANDA209938 ↗
Jul 2, 2026FINASTERIDE
FINASTERIDE
TEVA
Teva
Generic (ANDA), supplement
Labeling
ANDA076511 ↗
Jun 26, 2026ARGATROBAN IN 0.9% SODIUM CHLORIDE
ARGATROBAN
TEVA
Teva Pharmaceuticals USA
New drug (NDA), supplement
Labeling
NDA206769 ↗
Jun 26, 2026NILOTINIB HYDROCHLORIDE
NILOTINIB HYDROCHLORIDE
TEVA
Teva Pharmaceuticals Inc
Generic (ANDA)
UNKNOWN
ANDA219134 ↗
Jun 22, 2026COPAXONE
GLATIRAMER ACETATE
TEVA
Teva Pharmaceuticals USA
New drug (NDA), supplement
Labeling
NDA020622 ↗
Jun 22, 2026LO JUNEL FE
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
TEVA
Teva Pharmaceuticals Inc
Generic (ANDA)
UNKNOWN
ANDA219324 ↗
Jun 18, 2026MORPHINE SULFATE
MORPHINE SULFATE
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
REMS
ANDA202718 ↗
Jun 18, 2026OXYMORPHONE HYDROCHLORIDE
OXYMORPHONE HYDROCHLORIDE
TEVA
Teva
Generic (ANDA), supplement
REMS
ANDA091443 ↗
Jun 18, 2026TRAMADOL HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE
TEVA
Teva
Generic (ANDA), supplement
REMS
ANDA075977 ↗
Jun 8, 2026MACITENTAN
MACITENTAN
TEVA
Teva Pharmaceuticals USA Inc
Generic (ANDA)
UNKNOWN
ANDA211187 ↗
Jun 8, 2026RISEDRONATE SODIUM
RISEDRONATE SODIUM
TEVA
Teva Pharmaceuticals USA
Generic (ANDA), supplement
Labeling
ANDA077132 ↗
Jun 5, 2026AJOVY
FREMANEZUMAB-VFRM
TEVA
Teva Pharmaceuticals USA
Biologic (BLA), supplement
Labeling
BLA761089 ↗
May 27, 2026LINAGLIPTIN
LINAGLIPTIN
TEVA
Teva Pharmaceuticals USA
Generic (ANDA)
UNKNOWN
ANDA208433 ↗
Letter or label ↗
May 7, 2026LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
TEVA
Teva
Generic (ANDA), supplement
Labeling
ANDA076958 ↗
May 7, 2026GABAPENTIN
GABAPENTIN
TEVA
Teva Pharmaceuticals
Generic (ANDA), supplement
Labeling
ANDA075435 ↗

The newest 50 items, most recent first. Each row links to the FDA's page for the application, clearance or approval. Updated Nov 15, 2026, 7:44 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates